Comparison of clinical curative effect and inflammation factors between irbesartan hydrochlorothiazide and candesartan cilexetil in hypertension
10.3969/j.issn.1005-1678.2016.06.28
- VernacularTitle:厄贝沙坦氢氯噻嗪与坎地沙坦西酯对高血压患者炎症因子及临床疗效的比较
- Author:
Xin TAN
;
Xinwen LIU
;
Wenjuan WEI
- Publication Type:Journal Article
- Keywords:
irbesartan hydrochlorothiazide;
candesartan cilexetil;
hypertension;
CRP;
IL -6;
NO
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(6):100-102
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the comparison of clinical curative effect and inflammation factors between irbesartan hydrochlorothiazide and candesartan cilexetil in the treatment of patients with hypertension.Methods A total of 86 patients with hypertension in our hospital from June 2014 to October 2015 were collected and randomly divided into two groups, 43 cases in the control group were treated by candesartan cilexetil,43 cases in the experimental group were treated by irbesartan hydrochlorothiazide.The blood pressure, CRP, IL-6 and NO indexes were detected in the two groups and the clinical curative effect of the two groups was compared.Results The systolic pressure and diastolic pressure levels in the experimental group were significantly lower than the control group ( P <0.05 ); the serum CRP, IL -6 levels in experimental group were significantly lower than the control group, the NO level was significantly higher than the control group (P<0.05).Conclusion Irbesartan hydrochlorothiazide in the treatment of patients with hypertension has a better clinical curative effect, and higher security.
